Research Article
miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer
Table 1
Correlation of miR-31 expression level and clinicopathological data.
| Clinicopathological parameters | miR-31 expression | value | Low () | High () |
| Age (years) | | | | 40 | 13 | 16 | | >40 | 18 | 15 | 0.475 | Tumor size | | | | 5 cm | 17 | 15 | | >5 cm | 14 | 16 | 0.753 | Lymph node metastasis | | | | No | 19 | 10 | | Yes | 12 | 21 | 0.00 | FIGO stage | | | | IB | 22 | 8 | | IIA | 9 | 23 | 0.00 | Vascular invasion | | | | No | 24 | 14 | | Yes | 7 | 17 | 0.00 | Stromal invasion | | | | 2/3 | 25 | 5 | | 2/3 | 6 | 26 | 0.00 | Differentiation | | | | Well | 15 | 12 | | Poor | 16 | 19 | 0.174 | Peritoneal metastasis | | | | No | 18 | 10 | | Yes | 13 | 21 | 0.128 | Histological type | | | | Serous | 14 | 23 | | Others | 17 | 8 | 0.02 |
|
|
.
|